ID: ALA3228393

Max Phase: Preclinical

Molecular Formula: C7H11IN2

Molecular Weight: 122.17

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Cc1ccn(C)c(=N)c1.I

Standard InChI:  InChI=1S/C7H10N2.HI/c1-6-3-4-9(2)7(8)5-6;/h3-5,8H,1-2H3;1H

Standard InChI Key:  FYZOLDNEGRSROJ-UHFFFAOYSA-N

Associated Targets(non-human)

INMT Indolethylamine N-methyltransferase (82 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 122.17Molecular Weight (Monoisotopic): 122.0844AlogP: 0.81#Rotatable Bonds: 0
Polar Surface Area: 28.78Molecular Species: BASEHBA: 2HBD: 1
#RO5 Violations: 0HBA (Lipinski): 2HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 13.58CX LogP: 0.65CX LogD: -1.77
Aromatic Rings: 1Heavy Atoms: 9QED Weighted: 0.53Np Likeness Score: -0.65

References

1. Rokach J, Hamel P, Hunter NR, Reader G, Rooney CS, Anderson PS, Cragoe EJ, Mandel LR..  (1979)  Cyclic amidine inhibitors of indolamine N-methyltransferase.,  22  (3): [PMID:423205] [10.1021/jm00189a004]

Source